VICTOR L. YU, M.D.; JEFFREY J. ZURAVLEFF, M.S.; ELAINE M. ELDER, SC.D.; ARNOLD BROWN, M.D.
The pittsburgh pneumonia agent is a newly recognized cause of pneumonia (1, 2). Although most patients have been renal transplant recipients (1-4), others have had malignant disease or received corticosteroid treatment (2, 3, 5). A common feature in all these patients was the development of pneumonia during or shortly after immunosuppressive therapy, although recently two cases were reported in non-immunosuppressed patients (6). Almost 50% of these reported patients died of the pneumonia.
As part of a serologic survey for Legionnaires' disease, we did a simultaneous survey for Pittsburgh pneumonia agent using an enzyme-linked immunosorbent assay (7) from the TATLOCK strain
Learn more about subscription options.
Register Now for a free account.
YU VL, ZURAVLEFF JJ, ELDER EM, BROWN A. Pittsburgh Pneumonia Agent May Be a Common Cause of Nosocomial Pneumonia: Seroepidemiologic Evidence. Ann Intern Med. 1982;97:724–726. doi: 10.7326/0003-4819-97-5-724
Download citation file:
Published: Ann Intern Med. 1982;97(5):724-726.
Hospital Medicine, Hospital-Acquired Infections, Infectious Disease, Pneumonia, Pulmonary/Critical Care.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only